Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350,000 Compounds
被引:55
作者:
Baell, Jonathan B.
论文数: 0引用数: 0
h-index: 0
机构:
Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia
Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, AustraliaMonash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
ORGANIC SMALL MOLECULES;
HIGH-THROUGHPUT;
DRUG DISCOVERY;
CHEMICAL SPACE;
REACTIVE COMPOUNDS;
FALSE POSITIVES;
VINYL SULFONES;
DIVERSITY;
LIBRARIES;
DESIGN;
D O I:
10.1021/ci300461a
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
In establishing what we propose is the globe's highest quality collection of available screening compounds, it is convincingly shown that the globe's pool of such compounds is extremely shallow and can be represented by fewer than 350,000 compounds. To support our argument, we discuss and fully disclose our extensive battery of functional group filters. We discuss the use of PAINS filters and also show the effect of similarity exclusion on structure-activity relationships. We show why limited analogue representation requires screening at higher concentrations to capture hit classes for difficult targets that otherwise may be prosecuted unsuccessfully. We construct our arguments in a structurally focused manner to be most useful to medicinal chemists, the key players in drug discovery.